Skip to content

GUARDION HEALTH SCIENCES, INC.: 10-Q filed 2020-08-12

What GUARDION HEALTH SCIENCES, INC. reported in its quarterly report filed 2020-08-12 (fiscal Q2 2020): 38 published measures, 100 facts as tagged in accession 0001493152-20-015346.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-12
Fiscal period
fiscal Q2 2020
Accession
0001493152-20-015346 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GUARDION HEALTH SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-3014,034,003USD
At 2019-12-3112,876,821USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-301,338,363USD
At 2019-12-31844,981USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-3012,695,640USD
At 2020-03-3113,739,601USD
At 2019-12-3112,031,840USD
At 2019-06-304,688,088USD
At 2019-03-311,888,146USD
At 2018-12-313,185,763USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-3011,603,459USD
At 2019-12-3111,115,502USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-707,160USD91
2020-01-01 to 2020-06-30-3,054,073USD182
2020-01-01 to 2020-03-31-2,346,913USD91
2019-04-01 to 2019-06-30-3,048,348USD91
2019-01-01 to 2019-06-30-4,437,177USD181
2019-01-01 to 2019-03-31-1,385,099USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-4,020,731USD182
2019-01-01 to 2019-06-30-2,493,696USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-06-3040,733USD182
2019-01-01 to 2019-06-3058,934USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,190,909USD91
2020-01-01 to 2020-06-301,436,633USD182
2019-04-01 to 2019-06-30260,970USD91
2019-01-01 to 2019-06-30503,508USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-304,549,421USD182
2019-01-01 to 2019-06-304,250,327USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-40,733USD182
2019-01-01 to 2019-06-30-58,934USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-48,565,744USD
At 2019-12-31-45,511,671USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-30304,534USD
At 2019-12-31374,638USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-30109,388USD182
2019-01-01 to 2019-06-30242,996USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-708,226USD91
2020-01-01 to 2020-06-30-3,044,447USD182
2019-04-01 to 2019-06-30-2,812,194USD91
2019-01-01 to 2019-06-30-3,997,417USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-3013,171,331USD
At 2019-12-3111,867,718USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,790USD91
2020-01-01 to 2020-06-303,538USD182
2019-04-01 to 2019-06-30234,065USD91
2019-01-01 to 2019-06-30251,637USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-30983,236USD
At 2019-12-31410,234USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-30332,787USD
At 2019-12-3170,291USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-3034,180USD
At 2019-12-3178,337USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,254,556USD91
2020-01-01 to 2020-06-303,727,392USD182
2019-04-01 to 2019-06-302,976,108USD91
2019-01-01 to 2019-06-304,310,377USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-06-301,235,052USD
At 2019-12-31310,941USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30546,330USD91
2020-01-01 to 2020-06-30682,945USD182
2019-04-01 to 2019-06-30163,914USD91
2019-01-01 to 2019-06-30312,960USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-3044,581USD91
2020-01-01 to 2020-06-3075,769USD182
2019-04-01 to 2019-06-3077,688USD91
2019-01-01 to 2019-06-30106,716USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-3088,309,962shares
At 2019-12-3174,982,562shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-3061,173,074USD
At 2019-12-3157,468,528USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-30496,387USD
At 2019-12-31572,714USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-30512,246USD
At 2019-12-31586,315USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-06-30711,101USD
At 2019-12-31755,236USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-30406,567USD
At 2019-12-31380,598USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-06-3050,000USD
At 2019-12-3150,000USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-3011,751USD
At 2019-12-3111,751USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-30162,461USD
At 2019-12-31175,052USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,712,183USD91
2020-01-01 to 2020-06-303,228,698USD182
2019-04-01 to 2019-06-302,489,011USD91
2019-01-01 to 2019-06-303,439,633USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-01-01 to 2020-06-3046,619USD182
2019-01-01 to 2019-06-3029,810USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-1,066USD91
2020-01-01 to 2020-06-309,626USD182
2019-04-01 to 2019-06-30236,154USD91
2019-01-01 to 2019-06-30439,760USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-44,157USD182
2019-01-01 to 2019-06-307,718USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30607,162USD182
2019-01-01 to 2019-06-30-39,311USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30262,496USD182
2019-01-01 to 2019-06-30156,314USD181

Inspect the source

Entity
GUARDION HEALTH SCIENCES, INC. / CIK 0001642375
Captured
SEC response SHA-256
315f181c3e956f67588df46180e70e40d4179f5dc4690a92dcd821db8004b7eb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001642375.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))